Sigachi Indust.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0D0K01022
  • NSEID: SIGACHI
  • BSEID: 543389
INR
20.78
0.28 (1.37%)
BSENSE

Jun 12, 03:30 PM

BSE+NSE Vol: 5.0 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

5.0 lacs (3.34%) Volume

Shareholding (Mar 2026)

FII

1.30%

Held by 12 FIIs

DII

0.00%

Held by 1 DIIs

Promoter

36.69%

Why is Sigachi Industries Ltd falling/rising?

12-Jun-2026

As of 11-Jun, Sigachi Industries Ltd's stock price is at 20.50, reflecting a 3.16% decline and significant underperformance over various periods, including a 34.19% year-to-date drop. The stock shows mixed moving average signals and declining investor participation, indicating a lack of consistent upward momentum.

As of 11-Jun, Sigachi Industries Ltd's stock price is falling, currently at 20.50, which reflects a decrease of 0.67 or 3.16%. This decline is evident in the stock's performance over various periods, with a 1-week drop of 3.35%, a 1-month decrease of 6.78%, and a significant year-to-date decline of 34.19%. Over the past year, the stock has fallen by 63.16%, while the benchmark Sensex has only decreased by 10.52% during the same period, indicating a substantial underperformance relative to the market.<BR><BR>Today's performance shows that the stock has underperformed its sector by 1.51%. Additionally, the stock's moving averages indicate mixed signals; it is higher than the 20-day and 50-day moving averages but lower than the 5-day, 100-day, and 200-day moving averages. This suggests a lack of consistent upward momentum. Furthermore, there has been a notable decline in investor participation, with delivery volume falling by 13.05% compared to the 5-day average, which may indicate waning interest among investors. Overall, these factors contribute to the downward trend in Sigachi Industries Ltd's stock price.

View full answer

What does Sigachi Indust. do?

11-Jun-2026

Sigachi Industries Ltd is a Micro Cap company in the Pharmaceuticals & Biotechnology sector, originally founded in 1989 and publicly listed since 2019. As of March 2026, it reported net sales of 122 Cr and a net profit of 8 Cr, with a market cap of INR 809 Cr.

Overview:<BR>Sigachi Industries Ltd operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Micro Cap company.<BR><BR>History:<BR>The company was originally incorporated as 'Sigachi Chloro-Chemicals Private Limited' in 1989. It changed its name to 'Sigachi Industries Private Limited' in 2012 to diversify its business activities and was converted to a Public Limited company, adopting the name 'Sigachi Industries Limited' in December 2019. The latest quarterly results reported net sales and net profit for March 2026.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 122 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 8 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 809 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 22.00 <BR>Industry P/E: 34 <BR>Dividend Yield: 0.48% <BR>Debt Equity: 0.22 <BR>Return on Equity: 6.99% <BR>Price to Book: 1.54 <BR><BR>Contact Details:<BR>Details: No Company Details Available <BR>Registrar Address: Not available.

View full answer

How big is Sigachi Indust.?

11-Jun-2026

As of 10th June, Sigachi Industries Ltd has a market capitalization of 809.00 Cr, with recent net sales of 477.84 Cr and a net loss of 81.75 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: Sigachi Industries Ltd has a market capitalization of 809.00 Cr and is classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 477.84 Cr, while the sum of Net Profit for the same period shows a loss of 81.75 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is March 2025. Shareholder's Funds are valued at 600.85 Cr, and Total Assets amount to 846.21 Cr.

View full answer

Who are in the management team of Sigachi Indust.?

11-Jun-2026

The management team of Sigachi Industries includes Chairman Rabindra Prasad Sinha, Vice Chairman Chidambarnathan Shanmuganathan, Managing Director & CEO Amit Raj Sinha, and three Independent Non-Executive Directors: Sarveswar Reddy Sanivarapu, Dhanalakshmi Guntaka, and Bindu Vinodhan. They are responsible for the company's strategic direction and operations.

The management team of Sigachi Industries includes the following key individuals:<BR><BR>1. **Rabindra Prasad Sinha** - Chairman & Wholetime Director<BR>2. **Chidambarnathan Shanmuganathan** - Vice Chairman & Whole Time Director<BR>3. **Amit Raj Sinha** - Managing Director & CEO<BR>4. **Sarveswar Reddy Sanivarapu** - Independent Non-Executive Director<BR>5. **Dhanalakshmi Guntaka** - Independent Non-Executive Director<BR>6. **Bindu Vinodhan** - Independent Non-Executive Director<BR><BR>This team plays a crucial role in guiding the company's strategic direction and operations.

View full answer

Who are the peers of the Sigachi Indust.?

11-Jun-2026

Sigachi Industries' peers include Bharat Parenter., Wanbury, Kopran, Anlon Healthcare, Anuh Pharma, Shree Ganesh Rem, Kilitch Drugs, Zim Laboratories, and Remus Pharma. Sigachi has average management risk, below-average growth, and the lowest 1-year return at -62.71% among its peers.

Peers: The peers of Sigachi Indust. are Bharat Parenter., Wanbury, Kopran, Anlon Healthcare, Anuh Pharma, Shree Ganesh Rem, Kilitch Drugs, Zim Laboratories, and Remus Pharma.<BR><BR>Quality Snapshot: Excellent management risk is observed at Anlon Healthcare, Remus Pharma, and Influx Health, while Average management risk is found at Bharat Parenter., Wanbury, Kopran, Sigachi Indust., Anuh Pharma, Shree Ganesh Rem, Zim Laboratories, and the rest. Growth is Excellent at Anlon Healthcare and Kilitch Drugs, Good at Wanbury and Remus Pharma, while Below Average growth is noted for Bharat Parenter., Kopran, Sigachi Indust., Anuh Pharma, Shree Ganesh Rem, Zim Laboratories, and the rest. Capital Structure is Excellent at Sigachi Indust., Anuh Pharma, Shree Ganesh Rem, and Good at Wanbury, Kopran, Anlon Healthcare, Kilitch Drugs, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Zim Laboratories at 4.71%, while Sigachi Indust. has the lowest at -62.71%. Sigachi Indust.'s return is significantly lower than Zim Laboratories'. Additionally, peers with a negative six-month return include Sigachi Indust. and Anuh Pharma.

View full answer

Should I buy, sell or hold Sigachi Industries Ltd?

03-Jun-2026

Are Sigachi Industries Ltd latest results good or bad?

02-Jun-2026

Sigachi Industries Ltd's latest results show a strong quarter-on-quarter profit increase of 3,755% and a 4% rise in net sales, indicating short-term recovery. However, year-on-year declines in both net profit (down 41.90%) and net sales (down 4.91%), along with reduced operating margins, suggest ongoing operational challenges.

Sigachi Industries Ltd's latest results present a mixed picture. On one hand, the company reported a significant quarter-on-quarter increase in net profit, soaring by 3,755% to ₹7.71 crore compared to just ₹0.20 crore in the previous quarter. This indicates a strong recovery in profitability on a sequential basis. Additionally, net sales grew by 4.00% to ₹121.90 crore, which is a positive sign of revenue growth.<BR><BR>However, when looking at year-on-year performance, the results are concerning. Both net profit and net sales have declined compared to the same quarter last year, with net profit down by 41.90% and net sales down by 4.91%. The operating margin also reflects challenges, having decreased from 22.27% in Q4 FY25 to 13.46% in Q4 FY26, indicating persistent cost pressures and operational inefficiencies.<BR><BR>Overall, while there are signs of improvement in the short term, the year-on-year declines and margin compression suggest that the company is still facing significant operational challenges. Investors should weigh these factors carefully when considering the company's performance.

View full answer

When is the next results date for Sigachi Industries Ltd?

26-May-2026

The next results date for Sigachi Industries Ltd is 30 May 2026.

The next results date for Sigachi Industries Ltd is scheduled for 30 May 2026.

View full answer

Is Sigachi Indust. technically bullish or bearish?

03-Dec-2025

As of December 2, 2025, Sigachi Industries is in a bearish trend with moderate strength, indicated by bearish MACD, Bollinger Bands, and moving averages, despite some mixed signals from KST and Dow Theory.

As of 2 December 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance for Sigachi Industries is bearish with a moderate strength. Key indicators driving this stance include a bearish MACD on the weekly chart, bearish Bollinger Bands on both weekly and monthly time frames, and bearish moving averages on the daily chart. The KST shows a mildly bullish signal on the weekly chart but is bearish on the monthly, while Dow Theory indicates a mildly bullish stance weekly but mildly bearish monthly. Overall, the combination of these indicators suggests a prevailing bearish sentiment in the market.

View full answer

How has been the historical performance of Sigachi Indust.?

24-Oct-2025

Sigachi Industries has shown consistent growth from Mar'20 to Mar'25, with net sales increasing from 139.06 Cr to 488.24 Cr and profit after tax rising from 20.32 Cr to 70.46 Cr, alongside improved operational efficiency reflected in cash flow. Total assets also grew significantly, indicating robust overall financial performance.

Answer:<BR>The historical performance of Sigachi Indust. shows a consistent growth trend across various financial metrics over the years.<BR><BR>Breakdown:<BR>Sigachi Indust. has demonstrated significant growth in net sales, increasing from 139.06 Cr in Mar'20 to 488.24 Cr in Mar'25. This upward trajectory is mirrored in total operating income, which rose from 139.06 Cr to 488.24 Cr during the same period. The company's total expenditure also increased, but at a slower pace, from 114.30 Cr in Mar'20 to 388.25 Cr in Mar'25, leading to an operating profit (PBDIT) growth from 29.65 Cr to 120.51 Cr. Profit before tax followed a similar trend, climbing from 25.34 Cr in Mar'20 to 92.32 Cr in Mar'25, while profit after tax increased from 20.32 Cr to 70.46 Cr. The earnings per share (EPS) saw fluctuations, peaking at 26.46 in Mar'20 and stabilizing at 1.82 in Mar'25. On the balance sheet, total assets grew from 109.14 Cr in Mar'20 to 846.21 Cr in Mar'25, with total liabilities also rising from 109.14 Cr to 846.21 Cr. Cash flow from operating activities improved from 12.00 Cr in Mar'20 to 26.00 Cr in Mar'25, indicating enhanced operational efficiency. Overall, Sigachi Indust. has shown robust growth in sales, profits, and asset accumulation over the years.

View full answer

Is Sigachi Indust. overvalued or undervalued?

26-Sep-2025

As of September 25, 2025, Sigachi Industries is fairly valued with a PE Ratio of 19.48 and an EV to EBITDA of 15.03, showing reasonable valuation compared to peers, despite a -30.02% return over the past year.

As of 25 September 2025, the valuation grade for Sigachi Industries has moved from expensive to fair. The company is currently fairly valued based on its financial metrics. Key ratios include a PE Ratio of 19.48, an EV to EBITDA of 15.03, and a ROE of 11.58%. <BR><BR>When compared to peers, Sigachi's valuation appears reasonable; for instance, Sun Pharma has a PE Ratio of 33.99, while Dr. Reddy's Labs, which is considered attractive, has a PE of 18.72. Additionally, the PEG Ratio for Sigachi stands at 1.72, indicating growth potential relative to its price. Notably, Sigachi's stock has underperformed the Sensex over the past year, with a return of -30.02% compared to the Sensex's -4.71%, reinforcing the notion that it is fairly valued in the current market context.

View full answer

Who are the top shareholders of the Sigachi Indust.?

06-Jun-2025

The top shareholder of Sigachi Industries is Rps Industries Private Limited with 19.71%, while individual investors own 42.9%. Rakesh Yadav is the largest public shareholder at 2.8%, and 44.04% of promoter holdings are pledged.

The top shareholders of Sigachi Industries include Rps Industries Private Limited, which holds the highest stake at 19.71%. Additionally, individual investors collectively own 42.9% of the company. The highest public shareholder is Rakesh Yadav, with a holding of 2.8%. The company also has 44.0375% of its promoter holdings pledged. In terms of institutional investors, there are 2 mutual fund schemes with no holdings and 7 foreign institutional investors (FIIs) holding a total of 0.08%.

View full answer

Has Sigachi Indust. declared dividend?

06-Jun-2025

Yes, Sigachi Industries Ltd has declared a 10% dividend, amounting to ₹0.10 per share, with an ex-date of August 28, 2024. The company's total returns have varied over different periods, with a total return of 128.57% over two years, despite some negative performance in shorter time frames.

Sigachi Industries Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: ₹0.10<BR>- Ex-date: 28 Aug 2024<BR><BR>Dividend Yield: 0.18%<BR><BR>Total Returns by Period:<BR>Over the 6-month period, the price return was 3.17%, with no dividend return, resulting in a total return of 3.17%.<BR><BR>In the 1-year period, the price return was -13.6%, the dividend return was 0.16%, leading to a total return of -13.44%.<BR><BR>For the 2-year period, the price return was 124.14%, the dividend return was 4.43%, resulting in a total return of 128.57%.<BR><BR>During the 3-year period, the price return was 101.39%, the dividend return was 8.74%, yielding a total return of 110.13%.<BR><BR>In the 4-year period, there was no price return or dividend return, resulting in a total return of 0.0%.<BR><BR>Over the 5-year period, there was also no price return or dividend return, leading to a total return of 0.0%.<BR><BR>Overall, Sigachi Industries Ltd has declared a dividend, and while the recent total returns show a mix of positive and negative performance over various periods, the declared dividend indicates a commitment to returning value to shareholders.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Operating profit has grown by an annual rate -7.84% of over the last 5 years

 
2

The company has declared Negative results for the last 3 consecutive quarters

3

27.71% of Promoter Shares are Pledged

4

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 795 Cr (Micro Cap)

stock-summary
P/E

22.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

0.48%

stock-summary
Debt Equity

0.22

stock-summary
Return on Equity

6.99%

stock-summary
Price to Book

1.53

Revenue and Profits:
Net Sales:
122 Cr
(Quarterly Results - Mar 2026)
Net Profit:
8 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.48%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
8.06%
0%
8.06%
6 Months
-40.68%
0%
-40.68%
1 Year
-63.82%
0.18%
-63.64%
2 Years
-68.2%
0.32%
-67.88%
3 Years
-17.39%
3.87%
-13.52%
4 Years
-23.18%
7.97%
-15.21%
5 Years
0%
0%
0.0%

Latest dividend: 0.1 per share ex-dividend date: Sep-16-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

05-Jun-2026 | Source : BSE

Transcript of Earnings call Q4 FY 2025-26

Announcement under Regulation 30 (LODR)-Newspaper Publication

01-Jun-2026 | Source : BSE

Newspaper Publication

Corporate Action-Board approves Dividend

30-May-2026 | Source : BSE

Board recommended final dividend of Re 0.10 per share subject to approval of members at ensuing Annual General Meeting

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Sigachi Industries Ltd has declared 10% dividend, ex-date: 16 Sep 25

stock-summary
SPLITS

Sigachi Industries Ltd has announced 1:10 stock split, ex-date: 09 Oct 23

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
17.55%
EBIT Growth (5y)
-7.84%
EBIT to Interest (avg)
14.58
Debt to EBITDA (avg)
1.31
Net Debt to Equity (avg)
0.22
Sales to Capital Employed (avg)
0.84
Tax Ratio
5.59%
Dividend Payout Ratio
5.49%
Pledged Shares
27.71%
Institutional Holding
1.31%
ROCE (avg)
16.47%
ROE (avg)
13.14%

Valuation key factors

Factor
Value
P/E Ratio
22
Industry P/E
34
Price to Book Value
1.53
EV to EBIT
25.26
EV to EBITDA
17.00
EV to Capital Employed
1.44
EV to Sales
1.91
PEG Ratio
NA
Dividend Yield
0.48%
ROCE (Latest)
5.70%
ROE (Latest)
6.99%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

27.7119

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 12 FIIs (1.3%)

Promoter with highest holding

Rps Industries Private Limited (15.02%)

Highest Public shareholder

Rakesh Yadav (2.65%)

Individual Investors Holdings

54.61%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 4.00% vs 6.09% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 3,755.00% vs -98.13% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "121.90",
          "val2": "117.21",
          "chgp": "4.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.41",
          "val2": "5.71",
          "chgp": "187.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.33",
          "val2": "3.13",
          "chgp": "38.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.14",
          "val2": "-0.73",
          "chgp": "-56.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.71",
          "val2": "0.20",
          "chgp": "3,755.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.46%",
          "val2": "4.87%",
          "chgp": "8.59%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 8.21% vs 19.98% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -356.64% vs 34.44% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "238.73",
          "val2": "220.62",
          "chgp": "8.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "31.63",
          "val2": "38.26",
          "chgp": "-17.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "6.44",
          "val2": "5.26",
          "chgp": "22.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-116.35",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-89.67",
          "val2": "34.94",
          "chgp": "-356.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.25%",
          "val2": "17.34%",
          "chgp": "-4.09%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -1.14% vs 22.12% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -258.94% vs 33.71% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "355.94",
          "val2": "360.04",
          "chgp": "-1.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "37.34",
          "val2": "71.44",
          "chgp": "-47.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "9.57",
          "val2": "9.08",
          "chgp": "5.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-117.08",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-89.47",
          "val2": "56.29",
          "chgp": "-258.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.49%",
          "val2": "19.84%",
          "chgp": "-9.35%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -2.13% vs 22.38% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -217.54% vs 21.65% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "477.83",
          "val2": "488.24",
          "chgp": "-2.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "53.74",
          "val2": "99.99",
          "chgp": "-46.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "13.90",
          "val2": "12.41",
          "chgp": "12.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-118.21",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-81.76",
          "val2": "69.56",
          "chgp": "-217.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.25%",
          "val2": "20.48%",
          "chgp": "-9.23%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
121.90
117.21
4.00%
Operating Profit (PBDIT) excl Other Income
16.41
5.71
187.39%
Interest
4.33
3.13
38.34%
Exceptional Items
-1.14
-0.73
-56.16%
Consolidate Net Profit
7.71
0.20
3,755.00%
Operating Profit Margin (Excl OI)
13.46%
4.87%
8.59%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is 4.00% vs 6.09% in Dec 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 3,755.00% vs -98.13% in Dec 2025

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
238.73
220.62
8.21%
Operating Profit (PBDIT) excl Other Income
31.63
38.26
-17.33%
Interest
6.44
5.26
22.43%
Exceptional Items
-116.35
0.00
Consolidate Net Profit
-89.67
34.94
-356.64%
Operating Profit Margin (Excl OI)
13.25%
17.34%
-4.09%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 8.21% vs 19.98% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is -356.64% vs 34.44% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
355.94
360.04
-1.14%
Operating Profit (PBDIT) excl Other Income
37.34
71.44
-47.73%
Interest
9.57
9.08
5.40%
Exceptional Items
-117.08
0.00
Consolidate Net Profit
-89.47
56.29
-258.94%
Operating Profit Margin (Excl OI)
10.49%
19.84%
-9.35%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is -1.14% vs 22.12% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is -258.94% vs 33.71% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
477.83
488.24
-2.13%
Operating Profit (PBDIT) excl Other Income
53.74
99.99
-46.25%
Interest
13.90
12.41
12.01%
Exceptional Items
-118.21
0.00
Consolidate Net Profit
-81.76
69.56
-217.54%
Operating Profit Margin (Excl OI)
11.25%
20.48%
-9.23%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is -2.13% vs 22.38% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is -217.54% vs 21.65% in Mar 2025

stock-summaryCompany CV
About Sigachi Industries Ltd stock-summary
stock-summary
Sigachi Industries Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Sigachi Industries Limited was originally incorporated as 'Sigachi Chloro-Chemicals Private Limited' on 11 January, 1989. To diversify the business activities, name of the Company was changed to 'Sigachi Industries Private Limited' on 29 March, 2012. Subsequently, Company was converted from a Private Limited to a Public Limited and consequently, name was changed to 'Sigachi Industries Limited' effective on 19 December, 2019.
Company Coordinates stock-summary
Icon
No Company Details Available